Links between mTOR and the immunoproteasome: Therapeutic targets for cardiac hypertrophy?

J Mol Cell Cardiol. 2015 Dec;89(Pt B):113-5. doi: 10.1016/j.yjmcc.2015.09.014. Epub 2015 Sep 25.

Author

Maegen A Ackermann¹

Affiliation

¹ Wexner College of Medicine, Dorothy M. Davis Heart and Lung Research Institute, Department of Physiology and Cell Biology, The Ohio State University, Columbus, OH 43210, USA. Electronic address: [email protected].

PMID: 26409046
DOI: 10.1016/j.yjmcc.2015.09.014

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Animals
Cardiomegaly / genetics*
Humans
Proteasome Endopeptidase Complex / drug effects*
Sirolimus / administration & dosage*
TOR Serine-Threonine Kinases / genetics*

Substances

TOR Serine-Threonine Kinases
Proteasome Endopeptidase Complex
Sirolimus

Grants and funding